With low cell confluency and enough serum supplement, LATS1, the key component of the Hippo pathway, was increased in its phosphorylated form, which augmented YAP1 phosphorylation, suggesting the activation of Hippo pathway in ANLN-deficient ICC cells (Fig. 6B). Here, LATS1 is linked to intrahepatic cholangiocarcinoma.